We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$270M
AUM Growth
+$21.9M
Cap. Flow
-$21.6M
Cap. Flow %
-7.99%
Top 10 Hldgs %
47.67%
Holding
38
New
1
Increased
18
Reduced
12
Closed
5

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$3.45M
2
EQC
Equity Commonwealth
EQC
+$1.08M
3
AMLP icon
Alerian MLP ETF
AMLP
+$664K
4
RGLD icon
Royal Gold
RGLD
+$472K
5
FNV icon
Franco-Nevada
FNV
+$420K

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$8.33M
2
BIDU icon
Baidu
BIDU
+$5.85M
3
MTZ icon
MasTec
MTZ
+$3.26M
4
GILD icon
Gilead Sciences
GILD
+$2.96M
5
LEN icon
Lennar Class A
LEN
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Healthcare 18.22%
3 Industrials 17.47%
4 Consumer Discretionary 15.34%
5 Financials 11.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAB icon
26
Wabtec
WAB
$44.5B
$4.89M 1.81%
55,276
+312
+0.6% +$24.2K
FNV icon
27
Franco-Nevada
FNV
$38.7B
$3.18M 1.17%
20,853
+3,485
+20% +$420K
RGLD icon
28
Royal Gold
RGLD
$16.1B
$2.76M 1.02%
24,350
+4,426
+22% +$472K
PFE icon
29
Pfizer
PFE
$143B
$1.23M 0.45%
24,379
+640
+3% +$22.7K
MS icon
30
Morgan Stanley
MS
$339B
$1.11M 0.41%
10,805
– –
EQC
31
DELISTED
Equity Commonwealth
EQC
$1.01M 0.37%
+38,348
New +$1.08M
EPD icon
32
Enterprise Products Partners
EPD
$82.6B
$552K 0.2%
24,855
– –
RUSHB icon
33
Rush Enterprises Class B
RUSHB
$5.89B
$285K 0.11%
10,113
+72
+0.7% +$1.98K
BIDU icon
34
Baidu
BIDU
$36.5B
– –
-27,033
Closed -$5.85M
CTSH icon
35
Cognizant
CTSH
$21.2B
– –
-8,998
Closed -$737K
GILD icon
36
Gilead Sciences
GILD
$167B
– –
-50,803
Closed -$2.96M
JAZZ icon
37
Jazz Pharmaceuticals
JAZZ
$15.5B
– –
-50,460
Closed -$8.33M
BMY.RT
38
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-69,403
Closed -$48K
1
2

Similar funds

AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM
MW
Marks Wealth Annapolis, Maryland $380M AUM 40.02% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
RWA
Rooted Wealth Advisors Bourbonnais, Illinois $379M AUM 13.75% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $379M AUM 19.59% 1-Year Est. Return
BP
BWM Planning The Woodlands, Texas $379M AUM 21.72% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return

Muhlenkamp & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Muhlenkamp & Co held 38 positions worth $270M, up 8.8% from $248M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Muhlenkamp & Co withdrew a net $21.6M in Q1 2021, closing 5 positions and reducing 12 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $8.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Muhlenkamp & Co opened a new position in Equity Commonwealth worth $1.01M.

  • Muhlenkamp & Co's largest Q1 2021 buy was Equity Commonwealth: 38,348 shares worth $1.01M.
  • Muhlenkamp & Co added most to SLB Ltd in Q1 2021, an estimated $3.45M increase.
  • Muhlenkamp & Co's biggest Q1 2021 reduction was MasTec, cutting an estimated $3.26M.
  • Muhlenkamp & Co fully exited Jazz Pharmaceuticals in Q1 2021, selling an estimated $8.33M.
  • Muhlenkamp & Co's ten largest holdings make up 48% of its $270M portfolio in Q1 2021.
  • Muhlenkamp & Co opened 1 new position and closed 5 in Q1 2021.
  • Muhlenkamp & Co's portfolio value rose 8.8% quarter-over-quarter to $270M.

Based on Muhlenkamp & Co's 13F filing for Q1 2021, filed 18 Aug 2021.